Results 91 to 100 of about 2,560 (200)

Targeting CD44 and EpCAM with Antibody Dye Conjugates for the Photoimmunotherapy of Prostate Cancer

open access: yesAntibodies
Background/Objectives: Photoimmunotherapy (PIT) is an innovative approach for the targeted therapy of cancer. In PIT, photosensitizer dyes are conjugated to tumor-specific antibodies for targeted delivery into cancer cells.
Isis Wolf   +3 more
doaj   +1 more source

Near-Infrared Photoimmunotherapy (NIR-PIT) in Urologic Cancers

open access: yes, 2022
SIMPLE SUMMARY: Near-infrared photoimmunotherapy (NIR-PIT) is a novel molecularly-targeted therapy that induces rapid cancer cell death by systemically administering an antibody-photoabsorber conjugate (APC) that binds to cancer cells and irradiating NIR
Fukushima, Hiroshi   +11 more
core   +1 more source

Theranostic Near-Infrared Photoimmunotherapy [PDF]

open access: yes, 2019
Near-infrared photoimmunotherapy (NIR-PIT) is a newly developed cell-selective cancer therapy with enormous potential for treating cancer in a variety of ways. NIR-PIT not only kills cancer cells, but can also eliminate other unfavorable cells including cancer stem cells and immune-suppressor cells, among others, without damaging favorable cells such ...
openaire   +1 more source

Proton-Gradient-Driven Porphyrin-Based Liposome Remote-Loaded with Imiquimod as In Situ Nanoadjuvants for Synergistically Augmented Tumor Photoimmunotherapy

open access: yes
Cancer immunotherapy is expected to achieve tumor treatment mainly by stimulating the patient’s own immune system to kill tumor cells. However, the low immunogenicity of the tumor and the poor efficiency of tumor antigen presentation result in a variety ...
Dechun Liu (3152061)   +6 more
core   +1 more source

Photoimmunotherapy of gastric cancer peritoneal carcinomatosis in a mouse model. [PDF]

open access: yes, 2014
Photoimmunotherapy (PIT) is a new cancer treatment that combines the specificity of antibodies for targeting tumors with the toxicity induced by photosensitizers after exposure to near infrared (NIR) light.
Hisataka Kobayashi (1859)   +9 more
core   +1 more source

Manipulating the Crosstalk between Cancer and Immunosuppressive Cells with Phototherapeutic Gold‐Nanohut for Reprogramming Tumor Microenvironment

open access: yesAdvanced Science
Photoimmunotherapy faces challenges due to insufficient intratumoral accumulation of photothermal agents and the reversion of the cancer‐immunity cycle during treatment.
Hung‐Wei Cheng   +11 more
doaj   +1 more source

Cascade Amplification of Photoimmunotherapy via Mitochondrial Dual‐Ion Interference in a Bimetallic‐Organic Framework

open access: yes
Mitochondria‐targeted photodynamic immunotherapy has emerged as a promising strategy that combines organelle‐specific delivery with immunomodulation for cancer treatment.
Liangcan He   +12 more
core   +1 more source

Photo-generating Type-I ROS and aryl radicals by mitochondrial-targeting oxime-ester photogenerator for pyroptosis-mediated anti-hypoxia photoimmunotherapy

open access: yes
Pyroptosis is an inflammatory form of programmed cell death with great potential in cancer immunotherapies. Photodynamic therapy (PDT) represents a promising treatment modality to trigger pyroptosis.
Yanzhen Yang   +12 more
core   +1 more source

Next-Generation Cancer Treatment: Photoimmunotherapy’s Promise for Unresectable Head and Neck Cancers

open access: yes
Traditional oncological therapies have contributed to reducing the global cancer burden; however, they have not achieved complete eradication, nor have they effectively prevented relapses, minimized toxicity, or preserved immune function. Recent advances,
Constantin Ailioaie   +2 more
core   +1 more source

Home - About - Disclaimer - Privacy